Sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis

By sjmartinez • January 27, 2025

Ansari HUH, Samad MA, Mahboob E, Zulfiqar E, Qazi SU, Ahsan A, Ahmed M, Ahmed F, Ahmed R, Ali S, Alam M, Rana JS, Fonarow GC. Sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis. Am J Prev Cardiol. 2024 Dec 31;21:100927. doi: 10.1016/j.ajpc.2024.100927. PMID: 39867488; PMCID: PMC11757226.

Tags: Cardiology/Epi, myocardial infarction, percutaneous coronary intervention, Publications, Sodium-glucose co-transporter 2 inhibitors, Type 2 diabetes

Insurance-Based Disparities in Cardiac Allograft Vasculopathy After Heart Transplantation Are Mediated by Care at High-Volume Centers

Sakowitz S, Bakhtiyar SS, Mallick S, Pereira S, Nelson JS, Parikh R, Higgins RSD, Shemin RJ, Benharash P. Insurance-Based Disparities in Cardiac Allograft Vasculopathy After[...]

Engineering noncovalent π-stacked organic framework for intrinsic near-infrared photoactivated drug delivery

Fu R, Meng D, Han X, Liu L, Chen C, Zheng R, Zhao Y, Zhang X, Lin X, Hasani M, Song Y, Liang T, Wen[...]

Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System: Insights From Real-World Data

Waggoner T, Garcia S, Chakravarty T, Makar M, Latib A, Kipperman RM, Zahr F, Hanson I, Sinha AK, Sharma RP, Depta JP, Castellanos JA, Kodali[...]